{"nct_id":"NCT04455841","title":"INCB000928 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Anemia Due to Myeloproliferative Disorders","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-07","start_date":"2021-03-19","start_date_type":"ACTUAL","primary_completion_date":"2025-04-01","primary_completion_date_type":"ACTUAL","completion_date":"2027-11-26","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["INCY"]}